Login to Your Account

Tysabri Cleared; FDA Gives 'Very Rare' Second Approval

By Aaron Lorenzo

Tuesday, June 6, 2006
The FDA is allowing Tysabri to return to the market in a limited capacity for multiple sclerosis patients, three months after an advisory committee voted unanimously in favor of doing so. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription